Castle Biosciences (CSTL) Institutional Ownership

$19.51
-0.35 (-1.76%)
(As of 04/25/2024 ET)

Institutional Ownership Changes (13F Filings) for Castle Biosciences (NASDAQ:CSTL)

Current
Institutional Ownership
Percentage
92.60%
Number of
Institutional Buyers
(last 12 months)
62
Total
Institutional Inflows
(last 12 months)
$100.35M
Number of
Institutional Sellers
(last 12 months)
29
Total
Institutional Outflows
(last 12 months)
$46.94M
Get CSTL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Castle Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CSTL Institutional Buying and Selling by Quarter

Castle Biosciences Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/26/2024Tritonpoint Wealth LLC92,250$2.04M0.2%-2.2%0.336%
4/19/2024 Norden Group LLC24,673$547K0.0%N/A0.090%
4/19/2024 Denali Advisors LLC8,400$186K0.1%N/A0.031%
4/18/2024 Wasatch Advisors LP2,551,088$56.51M0.3%-1.5%9.294%
4/18/2024 Allspring Global Investments Holdings LLC10,862$241K0.0%+89.3%0.040%
2/15/2024Parkman Healthcare Partners LLC357,156$7.71M1.1%+59.0%1.327%
2/15/2024Granahan Investment Management LLC2,166,471$46.75M1.5%-12.9%8.051%
2/15/2024Birchview Capital LP10,000$216K0.2%N/A0.037%
2/14/2024 Wasatch Advisors LP2,590,951$55.91M0.3%-6.8%9.628%
2/14/2024Bellevue Group AG1,232,378$26.60M0.4%+0.4%4.579%
2/14/2024Invenomic Capital Management LP171,812$3.71M0.2%-39.9%0.638%
2/14/2024Intrinsic Edge Capital Management LLC326,270$7.04M0.7%+108.8%1.212%
2/13/2024Stephens Inc. AR43,579$940K0.0%-55.1%0.162%
2/12/2024Olympiad Research LP12,193$263K0.2%N/A0.045%
2/12/2024Millrace Asset Group Inc.78,914$1.70M1.7%+2.1%0.293%
2/9/2024Orion Portfolio Solutions LLC69,733$1.53M0.0%-5.8%0.259%
2/9/2024Assetmark Inc.4,736$102K0.0%+21.3%0.018%
2/7/2024Principal Financial Group Inc.1,585,673$34.22M0.0%+7.0%5.893%
2/7/2024Jump Financial LLC20,436$441K0.0%-14.9%0.076%
2/6/2024WuXi AppTec Co. Ltd.6,636$143K0.4%N/A0.025%
2/6/2024 Los Angeles Capital Management LLC18,201$393K0.0%-14.1%0.068%
2/6/2024Swiss National Bank50,200$1.08M0.0%-9.1%0.187%
2/5/2024Russell Investments Group Ltd.31,983$690K0.0%+10.3%0.119%
2/2/2024Truist Financial Corp11,630$251K0.0%-11.2%0.043%
2/1/2024New York State Common Retirement Fund237,126$5.12M0.0%-3.6%0.881%
1/31/2024Kornitzer Capital Management Inc. KS542,874$11.72M0.2%-16.3%2.017%
1/31/2024Knights of Columbus Asset Advisors LLC106,262$2.29M0.1%+99.2%0.395%
1/30/2024Zurcher Kantonalbank Zurich Cantonalbank 8,192$177K0.0%+20.5%0.030%
1/30/2024Strs Ohio24,100$520K0.0%-14.2%0.090%
1/25/2024 Allspring Global Investments Holdings LLC5,739$124K0.0%+943.5%0.021%
1/24/2024Tritonpoint Wealth LLC94,356$2.04M0.2%N/A0.351%
1/24/2024China Universal Asset Management Co. Ltd.3,110$67K0.0%+351.4%0.012%
1/22/2024Perkins Capital Management Inc.32,140$694K0.6%+10.2%0.119%
1/10/2024Dfpg Investments LLC13,649$284K0.0%-5.3%0.051%
12/19/2023Public Employees Retirement System of Ohio100,254$1.69M0.0%+22.9%0.373%
12/18/2023Vanguard Group Inc.1,439,388$24.31M0.0%+0.8%5.349%
12/6/2023Citigroup Inc.2,730$46K0.0%-75.6%0.010%
11/27/2023Banque Pictet & Cie SA203,275$3.43M0.0%+10.6%0.755%
11/21/2023Walleye Capital LLC170,786$2.89M0.0%N/A0.635%
11/17/2023Jacobs Levy Equity Management Inc.547,403$9.25M0.1%+112.0%2.034%
The World's First "$20 Trillion Drug?" (Ad)

One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

Get the name of the stock here >>>
11/16/2023Advisors Capital Management LLC116,890$1.97M0.1%+46.9%0.434%
11/15/2023GSA Capital Partners LLP52,195$882K0.1%+27.6%0.194%
11/14/2023Schonfeld Strategic Advisors LLC148,030$2.50M0.0%+294.4%0.550%
11/14/2023Deerfield Management Company L.P. Series C946,620$15.99M0.4%N/A3.518%
11/14/2023Numerai GP LLC68,163$1.15M0.4%+1.4%0.253%
11/13/2023Millrace Asset Group Inc.77,315$1.31M1.6%N/A0.287%
11/13/2023Connor Clark & Lunn Investment Management Ltd.80,585$1.36M0.0%+30.9%0.299%
11/13/2023Algert Global LLC67,212$1.14M0.1%-24.5%0.250%
11/7/2023Alpha DNA Investment Management LLC29,399$497K0.2%N/A0.110%
11/7/2023New York State Common Retirement Fund245,868$4.15M0.0%+1.9%0.917%
11/7/2023Jump Financial LLC24,000$405K0.0%+21.8%0.090%
11/6/2023Versor Investments LP14,543$246K0.0%N/A0.054%
11/6/2023 Los Angeles Capital Management LLC21,185$358K0.0%N/A0.079%
11/2/2023Principal Financial Group Inc.1,482,170$25.03M0.0%+9.0%5.528%
11/2/2023Bank Pictet & Cie Europe AG14,079$238K0.0%+14.8%0.053%
11/2/2023Perkins Capital Management Inc.29,160$493K0.5%-4.7%0.109%
11/2/2023Banque Pictet & Cie SA203,275$3.43M0.0%+10.6%0.758%
11/1/2023Knights of Columbus Asset Advisors LLC53,341$901K0.1%+106.2%0.199%
11/1/2023Orion Portfolio Solutions LLC74,027$1.25M0.0%-4.5%0.276%
10/27/2023Assetmark Inc.3,904$66K0.0%+34.2%0.015%
10/25/2023 BluePath Capital Management LLC1,811$31K0.0%N/A0.007%
10/25/2023Zurcher Kantonalbank Zurich Cantonalbank6,797$115K0.0%+74.8%0.025%
10/24/2023Bank of New York Mellon Corp81,141$1.37M0.0%+1.3%0.303%
10/24/2023Claybrook Capital LLC10,026$169K0.1%-25.9%0.037%
10/23/2023Commonwealth Equity Services LLC11,274$190K0.0%-26.3%0.042%
10/20/2023Harbor Capital Advisors Inc.9,747$165K0.0%-31.7%0.036%
10/17/2023Mach 1 Financial Group LLC26,034$440K0.2%N/A0.097%
10/11/2023AE Wealth Management LLC26,182$442K0.0%N/A0.098%
9/21/2023Barclays PLC9,510$131K0.0%-23.6%0.035%
9/1/2023 Portside Wealth Group LLC120,230$1.65M0.1%N/A0.448%
8/16/2023Stonepine Capital Management LLC91,978$1.26M0.5%-68.6%0.343%
8/15/2023Intrinsic Edge Capital Management LLC356,206$4.89M0.4%-10.0%1.329%
8/15/2023Capital Impact Advisors LLC16,554$227K0.2%+7.1%0.062%
8/14/2023Invenomic Capital Management LP278,818$3.83M0.2%+219.6%1.040%
8/14/2023Bellevue Group AG1,124,043$15.42M0.2%+18.5%4.193%
8/14/2023Portolan Capital Management LLC431,474$5.92M0.5%+68.1%1.609%
8/14/2023Palisade Capital Management LP602,204$8.26M0.2%+4.4%2.246%
8/14/2023Granahan Investment Management LLC2,529,431$34.70M1.1%+110.8%9.435%
8/11/2023Stonepine Capital Management LLC91,978$1.26M0.5%-68.6%0.343%
8/11/2023Numerai GP LLC67,200$922K0.2%N/A0.251%
8/11/2023ExodusPoint Capital Management LP63,773$875K0.0%+183.7%0.238%
8/8/2023 Wasatch Advisors LP3,087,001$42.35M0.3%+3.6%11.514%
8/7/2023Principal Financial Group Inc.1,360,001$18.66M0.0%+5.7%5.073%
8/4/2023Parallel Advisors LLC27,055$371K0.0%+22.6%0.101%
8/4/2023Banque Pictet & Cie SA183,803$2.52M0.0%-3.5%0.689%
8/3/2023Advisors Capital Management LLC79,572$1.09M0.0%+156.2%0.298%
8/3/2023Isthmus Partners LLC15,342$210K0.0%-76.2%0.057%
8/1/2023Signaturefd LLC28,390$390K0.0%+46.3%0.106%
8/1/2023 Portside Wealth Group LLC120,230$1.65M0.0%N/A0.450%
8/1/2023Truist Financial Corp12,899$177K0.0%N/A0.048%
The World's First "$20 Trillion Drug?" (Ad)

One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

Get the name of the stock here >>>
8/1/2023 Simon Quick Advisors LLC29,062$399K0.0%+11.8%0.109%
7/31/2023Strs Ohio28,100$385K0.0%+3.7%0.105%
7/24/2023 Allspring Global Investments Holdings LLC378,387$5.19M0.0%+2.7%1.418%
7/24/2023Dfpg Investments LLC16,152$276K0.0%N/A0.061%
7/18/2023 Allspring Global Investments Holdings LLC378,387$5.19M0.0%+2.7%1.418%
7/11/2023Harbor Capital Advisors Inc.14,264$196K0.0%N/A0.053%
5/25/2023 Legato Capital Management LLC27,534$626K0.1%+48.9%0.103%
5/15/2023Portolan Capital Management LLC256,649$5.83M0.6%-56.0%0.962%
5/15/2023RTW Investments LP258,498$5.87M0.1%-50.0%0.968%
5/15/2023Granahan Investment Management LLC1,200,049$27.27M0.8%+14.9%4.496%
(Data available from 1/1/2016 forward)

CSTL Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CSTL shares?

During the previous two years, 121 institutional investors and hedge funds held shares of Castle Biosciences. The most heavily invested institutionals were Wasatch Advisors LP ($56.51M), Granahan Investment Management LLC ($46.75M), Principal Financial Group Inc. ($34.22M), Bellevue Group AG ($26.60M), Grandeur Peak Global Advisors LLC ($24.44M), Vanguard Group Inc. ($24.31M), and Next Century Growth Investors LLC ($24.16M).Learn more on CSTL's institutional investors.

What percentage of Castle Biosciences stock is owned by institutional investors?

92.60% of Castle Biosciences stock is owned by institutional investors. Learn more on CSTL's institutional investor holdings.

Which institutional investors have been buying Castle Biosciences stock?

Of the 108 institutional investors that purchased Castle Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Granahan Investment Management LLC ($1.82M), Principal Financial Group Inc. ($1.22M), Deerfield Management Company L.P. Series C ($946.62K), Portolan Capital Management LLC ($603.57K), Essex Investment Management Co. LLC ($388.98K), Jacobs Levy Equity Management Inc. ($289.25K), and Kornitzer Capital Management Inc. KS ($289.22K).

How much institutional buying is happening at Castle Biosciences?

Institutional investors have bought a total of 9,795,002 shares in the last 24 months. This purchase volume represents approximately $207.66M in transactions.

Which Castle Biosciences major shareholders have been selling company stock?

Of the 58 institutional investors that sold Castle Biosciences stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: RTW Investments LP ($757.63K), Wasatch Advisors LP ($472.31K), Stonepine Capital Management LLC ($401.78K), Portolan Capital Management LLC ($327.07K), Granahan Investment Management LLC ($321.20K), Kornitzer Capital Management Inc. KS ($190.69K), and Allspring Global Investments Holdings LLC ($116.60K).

How much institutional selling is happening at Castle Biosciences?

Institutional investors have sold a total of 3,751,221 shares in the last 24 months. This volume of shares sold represents approximately $90.12M in transactions.


This page (NASDAQ:CSTL) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners